ROCKVILLE, Md. & EDMONTON, Alberta - Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) will present five posters with new data on its lupus nephritis medication LUPKYNIS (voclosporin) at two upcoming medical ...

Title: Real-world Data on Voclosporin for the Treatment of Lupus Nephritis Including Use of Concomitant Biologic Therapies: An Analysis of the ENLIGHT-LN Registry Presenting Author: Mohammad Kamgar, M ...

If you have been watching Aurinia Pharmaceuticals lately, you are not alone. With the stock closing at $11.27 and boasting a hair-raising 59.2% gain over the past year, it is no wonder investors are ...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today responded to a now retracted LinkedIn post referencing voclosporin by an FDA official. Aurinia stands behind the favorable benefit/risk profile of ...

Woman gardener pulling out weeds in garden - Ekaterina Savyolova/Getty Images When you're on the lookout for a ground cover for your garden, there are a few important factors you may want to consider.

Sometimes you want a plant that looks like it took a lot of effort, but in reality, couldn't be simpler to grow. If you're looking for a plant that will bloom with bright color in the spring and then ...

To prevent weed spread and enjoy an attractive greenery covering, try an easy-to-grow drought-tolerant ground cover. Turf grass, or zoysia, does not grow very well in dry soil, but most types of weeds ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2025 Earnings Call Transcript July 31, 2025 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.16 EPS, expectations were ...

EDMONTON, Alberta (AP) — EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported second-quarter earnings of $21.5 million. On a per-share basis, the Edmonton, Alberta-based ...